Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- Claim: LeCarre's "The Constant Gardener" Was Based on Pfizer Trovan Case
- The Connecticut Law Tribune claims that The Constant Gardener, a John Le Carré book and later a movie with the same name, is in fact based on the Pfizer Trovan case. But is the claim true? A look at the timeline of both the case and the book suggest it...
- Blog posts 2009-02-17
- Pfizer Settlement in Trovan Case Interrupted by Judge Who Wants Fairness Hearing
- A settlement in the Pfizer Trovan case looked so imminent that the governor of Nigeria's Kano state pictured reportedly headed to London to sign it today, but a U.S. judge ordered a hearing into whether the settlement is fair, and that is scheduled for June 1. Back...
- Blog posts 2009-05-11
Additional Resources
- Pfizer's Flip-Flop on the Trovan Settlement
- Pfizer is close to settling the Trovan case for $75 million, the Washington Post reported Saturday. BNET readers learned of this development on March 6. (Back story here.) Back then, Pfizer spokesperson waved BNET off the story, saying news of a settlement was "not accurate" because talks...
- Blog posts 2009-04-07
- Pfizer Trovan Case: Doctor Sues Over Link to Nigerian Attorney General Who Allegedly Wants Slice of Settlement
- A Texas doctor helping the Nigerian government in its claim against Pfizer in the Trovan drug testing case has sued an African investigative reporting website, SaharaReporters, for $25 million, according to Black Star News. SaharaReporters had written that the doctor was a cousin of Nigeria's attorney general and that the...
- Blog posts 2008-12-30
- Pfizer Biotech Chief Signs Vow of Silence for $1.7 Million
- Corey Goodman, the guy hired to run Pfizer's "Bioinnovation Center" in San Francisco, signed an omertà -style vow upon leaving the company: He must never talk about Pfizer again, to anyone, ever, the agreement basically states. Pfizer, which had too many R&D chiefs following its decision to merge...
- Blog posts 2009-04-28
- Europe to Ban Pfizer's Trovan.
- FOLLOWING A RECENT relabeling campaign on the part of Pfizer Inc. to notify physicians about limiting the use of Trovan trovafloxacin, the Committee for Proprietary Medicinal Products is recommending that the European Commission suspend the Europ FOLLOWING A RECENT relabeling campaign on the part...
- Research articles 1999-06-21
- Pfizer fights back against Trovan study allegations
- Pfizer Inc. has denied charges that a 1996 drug study conducted in Nigeria caused the deaths and brain damage of children, as so stated in a lawsuit filed in a U.S. district court in Manhattan on behalf of 30 children who participated in a study of the drug Trovan. The...
- Research articles 2001-10-01
- Pfizer's Trovan Settlement Demands Irk Nigerian Kleptocrats
- Pfizer is emerging as an unexpected champion of the poor against Nigeria’s kleptocracy as it negotiates a $75 million settlement in the Trovan case. by Jim Edwards
- Blog posts 2009-05-18
- UPDATED: Pfizer Settles Trovan Case for $75M; Nigerian Kleptocrats to Get $40M
- It's official: Pfizer has settled the Nigerian Trovan case for $75 million. Nigerian kleptocrats will probably take about $40 million of that settlement, according to the deal structure described by Reuters. by Jim Edwards
- Blog posts 2009-07-29
- List of Pfizer's Trovan Victims Has Been Lost, Nigerian Officials Say
- Nigerian officials have lost the list of victims to be compensated under Pfizer's $75 million settlement with the Kano State government following the Trovan meningitis trials in that country. The money was to be paid by Oct. 15, but the process has now been stretched out a further three months...
- Blog posts 2009-10-06
- Pfizer's Silence on Post-Wyeth Merger Job Cuts, Site Closures Has Everyone on Edge
- Pfizer is driving everyone nuts with its silence on which sites, offices and labs it will close following its merger with Wyeth. Even the Connecticut governor doesn't know what Pfizer's plans will be, even though the state has two sites -- Groton and New London -- and 5,000 jobs at...
- Blog posts 2009-10-09
- Pfizer Demands DNA of Trovan Victims Who Are Owed Compensation
- Victims covered by Pfizer's $75 million settlement of the Trovan meningitis case in Nigeria must produce DNA tests before they will receive their part of the payout, according to This Day, an African news web site. by Jim Edwards
- Blog posts 2009-11-02
- FDA says Trovan is still OK
- * Despite reports of fatal liver damage, Pfizer's Trovan trovafloxacin will stay on the market because its benefits still outweigh its risks, according to a just-released formal ruling by CDER Director Janet Woodcock. In a letter to Public Citizens Health Research Group, Woodcock said Trovan's broad-spectrum antibacterial activity makes it...
- Research articles 2000-04-01
- Stronger, healthier Pfizer - Inc
- Viagra, Zeldox and Trovan are just some of the products Pfizer Inc. is working on to lead it into the next century
- Research articles 1997-09-01
- Pfizer talking with FDA on labeling revisions
- Pfizer said in May it was in "advanced discussions" with the FDA about revisions to the labeling for Trovan trovafloxacin mesylate injection, a quinolone antibiotic indicated for treatment of infections caused by susceptible strains of designated microorganisms in conditions specified in the labeling. The discussions with the FDA come as...
- Research articles 1999-07-01
- Fake evidence: Court decision against Pfizer overturned
- A U.S. district court judge threw out a $143 million trademark infringement award, the largest ever levied in the U.S., against Pfizer for using Trovan as the name of the antibiotic trovafloxacin.
- Research articles 2000-07-01
- NEJM: Foreign Drug Trials Could Hurt U.S. Patients
- The increasing use of foreign drug trials may hurt U.S. patients because of genetic and environmental differences in overseas study subjects, a new study in the New England Journal of Medicine suggests. "Are trial results accurate and valid, and can they be extrapolated to other settings?" asks a team from...
- Blog posts 2009-02-19
- KILL BW0192, CA-ELEC-ID-DEVICES and KILL BW0245, CQN-CA-ELEC-ID-DEVICES
- Please KILL BW0192, (CA-ELEC-ID-DEVICES) Hearing on Profits Phase of Trovan Ltd. v. Pfizer Inc. Trademark Infringement Case Delayed Until December, which ran on Business Wire at 10:59 ET on 10/14/1999. Also KILL the CORRECTION, BW0245, (CQN-CA-ELEC-ID-DEVICES) Electronic Devices Corrects Release Issued Thursday, Oct. 14, which ran on Business Wire...
- Research articles 1999-10-14
- Trovan Ltd. Alleges Fraud Against Pfizer Inc., in Proposed Amended Complaint Filed in Dispute Over Trovan Trademark
- LOS ANGELES--BW HealthWire--May 11, 1999--
- Research articles 1999-05-11
- Hearing on Profits Phase of Trovan Ltd. v. Pfizer Inc. Trademark Infringement Case Delayed Until December
- LOS ANGELES--BW HealthWire--Oct. 14, 1999--
- Research articles 1999-10-14
- << Previous
- page 1 of 1
- Next >>
